Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,318,648 | 8,914,070 | 9,160,350 | 11,557,450 | 15,600,660 |
| Marketable Securities | 310,918 | 305,800 | 293,040 | 243,520 | 265,310 |
| Receivables | 8,612,561 | 8,860,550 | 9,290,590 | 8,285,950 | 8,508,350 |
| Inventories | 7,361,727 | 7,210,760 | 7,526,120 | 7,347,080 | 6,940,700 |
| Other current assets | 75,936 | 70,340 | 58,940 | 312,460 | 316,890 |
| TOTAL | $22,679,790 | $25,361,520 | $26,329,040 | $27,746,460 | $31,631,910 |
| Non-Current Assets | |||||
| PPE Net | 14,431,160 | 31,726,750 | N/A | N/A | N/A |
| Investments And Advances | 2,056,068 | 2,235,390 | 2,071,460 | 2,681,830 | 2,745,650 |
| Intangibles | 33,005,978 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 5,884,514 | 39,339,640 | 39,084,990 | 38,185,840 | 38,931,920 |
| TOTAL | $55,377,720 | $73,301,780 | $41,156,450 | $40,867,670 | $41,677,570 |
| Total Assets | $78,057,510 | $81,718,940 | $82,362,560 | $82,887,120 | $87,927,730 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,766,642 | 1,999,930 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 14,846,670 | 14,053,040 | 13,200,950 | 12,490,190 | 13,026,330 |
| Accrued Expenses | 1,683,540 | 2,172,700 | 2,476,140 | 2,798,230 | 4,087,400 |
| Other current liabilities | 1,646,287 | 2,288,910 | 1,886,950 | 2,055,400 | 1,907,250 |
| TOTAL | $19,943,140 | $20,514,590 | $19,768,870 | $21,129,950 | $23,933,150 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,565,170 | 23,430,400 | 23,424,950 | 22,508,390 | 23,076,550 |
| Other Non-Current Liabilities | 23,737,192 | 21,872,340 | 22,060,510 | 20,451,450 | 20,932,790 |
| TOTAL | $48,742,420 | $47,629,870 | $48,125,960 | $45,595,720 | $46,698,900 |
| Total Liabilities | $68,685,560 | $68,144,470 | $67,894,840 | $66,725,680 | $70,632,060 |
| Shareholders' Equity | |||||
| Common Shares | 1,919,952 | 2,048,860 | 2,077,670 | 2,050,810 | 2,030,050 |
| Retained earnings | -5,301,360 | -2,136,010 | -1,049,680 | 851,560 | 1,678,320 |
| Other shareholders' equity | 8,684,200 | 9,333,020 | 9,106,080 | 8,982,850 | 9,361,920 |
| TOTAL | $9,371,944 | $13,574,460 | $14,467,710 | $16,161,440 | $17,295,660 |
| Total Liabilities And Equity | $78,057,504 | $81,718,930 | $82,362,550 | $82,887,120 | $87,927,720 |